SB 699393 is a potent kinase inhibitor that functions as a selective inhibitor of cyclin-dependent kinase 2 (CDK2), a target investigated for its role in regulating cell cycle progression and uncontrolled… Read more
SB 699393 is a potent kinase inhibitor that functions as a selective inhibitor of cyclin-dependent kinase 2 (CDK2), a target investigated for its role in regulating cell cycle progression and uncontrolled cellular division in various malignancies. This category provides access to high-quality chemical materials essential for comprehensive analytical workflows. Pharmaceutical and research laboratories utilize these related compounds—including specific impurities, metabolites, and stable isotope labelled standards—as critical reference standards for precise drug analysis. These materials support rigorous impurity profiling, method validation, and quality control processes, ensuring the accurate identification and quantification of the parent drug and its degradation products. By providing these well-characterized reference materials, this collection facilitates the development of reliable assays and helps maintain analytical integrity throughout the research and development lifecycle of oncology-focused pharmaceutical compounds.